IGFL2 and breast carcinoma: According to previous studies, IGFL2‐AS1 can promote the Wnt/β‐catenin signaling pathway to activate the progression of tongue squamous cell carcinoma10; in breast cancer, IGFL2‐AS1, as a downstream gene of KLF5, promotes IGFL1 expression.11